🎉 Finosauras is now  SarasRead more
Glenmark Life Sciences Ltd logo

Alivus Life Sciences Limited

(NSE: ALIVUS)

Sector: Chemicals

Market Cap: 11501.62 Cr

951.75

+13.35 (1.40%)

CMP

As on 10 Feb 2026, 03:30 pm

Open
934.10
High
969.90
Low
934.10
Close
951.75
Previous Close
938.40

Returns

PeriodReturn %
1 Month6.43
3 Months2.26
1 Year--
5 Years--

Last updated on: 09/01/2026, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
Quant Mutual Fund - Quant Healthcare Fund2.51%3,080,136
Government Pension Fund Global2.09%2,563,000
ICICI Prudential Pharma Healthcare and Diaganostic1.29%1,576,606
Massachusetts Institute of Technology1.23%1,504,000

Last updated on: 12/31/2025, 12:00:00 AM

Latest Market News

Fundamental Data

Fundamental Analysis

P/E Ratio

21.15

P/B Ratio

3.63

PEG Ratio

8.73

ROE

18.94%

EPS

44.30

Dividend Yield

0.53%

Market Cap

11501.62 Cr

Sector

N/A

Last Updated: 10 Feb 2026, 02:30 pm

Loading peer comparison...

About : Alivus Life Sciences Ltd.

Incorporated Year

2011

City and State

Solapur, Maharashtra

Listing Date

Director's Name

Rudalf Corriea

Revenue

2396.75 Cr

Net Profit

485.63 Cr

FAQs